Clinical data including changes in physical health measures (weight , BMI and HbA1c) , and their mental health symptomatology screening , were used to describe the study sample and give context to the experiences of the individual participants
Type 2 diabetes have experienced a significant growth in 2023 and expected to dominate the market in the forecast period, due to a rise in the number of diabetic patients
Both contain the active ingredient Semaglutide and are the same medications, just prescribed at different doses
One of the most promising treatments available today is tirzepatide for weight loss, a cutting-edge medication that helps individuals shed excess weight while improving metabolic function
Both require a prescription, medical evaluation, and ongoing physician monitoring neither should be self-sourced or self-administered without supervision
For further inquiries, please contact us for personalized assistance